Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114269 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Anouk A Kruiswijk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; O…. Hauptthemen laut MEDLINE: Sarcoma, Precision Medicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Cancer Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; Orthopedic Surgery, Leiden University Medical Center, Albinusdreef 2, 2…
- Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, the Netherlands.
- Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- Orthopedic Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- Department of Surgical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
- Department of Radiotherapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
Förderung
- Dutch Cancer Society
Zitieren
APA
Kruiswijk, A. A., Engelhardt, E. G., Vlug, L. A. E., van de Wal, R. J. P., Schrage, Y. M., Haas, R. L., van de Sande, M. A. J., Marang-van de Mheen, P. J., van Bodegom-Vos, L., & VALUE-PERSARC research group (2024). Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114269
Vancouver
Kruiswijk AA, Engelhardt EG, Vlug LAE, van de Wal RJP, Schrage YM, Haas RL, et al. Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114269
BibTeX
@article{Kruiswijk2024,
author = {Kruiswijk, Anouk A and Engelhardt, Ellen G and Vlug, Lisa A E and van de Wal, Robert J P and Schrage, Yvonne M and Haas, Rick L and van de Sande, Michiel A J and Marang-van de Mheen, Perla J and van Bodegom-Vos, Leti and VALUE-PERSARC research group, VALUE-PERSARC research group},
title = {Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114269}
}
EUVIMED